These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21918520)

  • 1. Endogenic and iatrogenic diabetes mellitus in drug-naïve schizophrenia: the role of olanzapine and its place in the psychopharmacological treatment algorithm.
    Cohen D; De Hert M
    Neuropsychopharmacology; 2011 Oct; 36(11):2368-9. PubMed ID: 21918520
    [No Abstract]   [Full Text] [Related]  

  • 2. Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naïve schizophrenia patients.
    Nielsen J; Skadhede S; Correll CU
    Neuropsychopharmacology; 2010 Aug; 35(9):1997-2004. PubMed ID: 20520598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential for detection bias in the association between olanzapine and diabetes.
    Compton MT; Hill HA
    J Clin Psychiatry; 2004 Feb; 65(2):274; author reply 275. PubMed ID: 15003085
    [No Abstract]   [Full Text] [Related]  

  • 4. Considerations regarding the use of metformin with olanzapine.
    Alamiri B
    Am J Psychiatry; 2008 Sep; 165(9):1205-6; author reply 1207. PubMed ID: 18765498
    [No Abstract]   [Full Text] [Related]  

  • 5. A patient treated with olanzapine developing diabetes de novo: proposal for hyperglycaemia screening.
    Duiverman ML; Cohen D; van Oven W; Nieboer P
    Neth J Med; 2007 Oct; 65(9):346-8. PubMed ID: 17954954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetes as a complication in treatment with second-generation antipsychotics].
    Povlsen UJ; Breum L; Lublin HK
    Ugeskr Laeger; 2004 Aug; 166(35):2977-9. PubMed ID: 15387005
    [No Abstract]   [Full Text] [Related]  

  • 7. Olanzapine use in a patient with schizophrenia and the risk of diabetes.
    Folnegović-Smalc V; Jukić V; Kozumplik O; Mimica N; Uzun S
    Eur Psychiatry; 2004 Feb; 19(1):62-4. PubMed ID: 14969784
    [No Abstract]   [Full Text] [Related]  

  • 8. Risperidone alternative for a schizophrenic patient with olanzapine-exacerbated diabetic mellitus.
    Wu PL; Lane HY; Su KP
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):115-6. PubMed ID: 16472369
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes resolution following discontinuation of a second-generation antipsychotic.
    Strassnig M; Awerbuck J; Ganguli R
    Clin Schizophr Relat Psychoses; 2013 Jan; 6(4):202-3. PubMed ID: 23302450
    [No Abstract]   [Full Text] [Related]  

  • 10. What evidence is there to show which antipsychotics are more diabetogenic than others?
    Jesus C; Jesus I; Agius M
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S423-8. PubMed ID: 26417808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of preexisting diabetes with olanzapine.
    Littrell KH; Petty RG; Peabody CD; Hilligoss NM; Johnson CG
    J Clin Psychiatry; 2001 Sep; 62(9):733-4. PubMed ID: 11681771
    [No Abstract]   [Full Text] [Related]  

  • 12. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
    Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine-induced diabetes in a seven-year-old boy.
    Courvoisie HE; Cooke DW; Riddle MA
    J Child Adolesc Psychopharmacol; 2004; 14(4):612-6. PubMed ID: 15662154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine-associated type 2 diabetes mellitus.
    Opp D; Hildebrandt C
    Schizophr Res; 2002 Jul; 56(1-2):195-6. PubMed ID: 12084434
    [No Abstract]   [Full Text] [Related]  

  • 15. Unusual suspect for antipsychotic-induced diabetes.
    O'Neill MF
    Drug Discov Today; 2005 Oct; 10(20):1338. PubMed ID: 16253867
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucose metabolism in Japanese schizophrenia patients treated with risperidone or olanzapine.
    Yasui-Furukori N; Sato Y; Furukori H; Saito M; Nakagami T; Kaneko S
    J Clin Psychiatry; 2009 Jan; 70(1):95-100. PubMed ID: 19026267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder.
    van Winkel R; De Hert M; Wampers M; Van Eyck D; Hanssens L; Scheen A; Peuskens J
    J Clin Psychiatry; 2008 Mar; 69(3):472-9. PubMed ID: 18348593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic parameters and long-term antipsychotic treatment: a comparison between patients treated with clozapine or olanzapine.
    Feng S; Melkersson K
    Neuro Endocrinol Lett; 2012; 33(5):493-8. PubMed ID: 23090266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.
    Henderson DC; Cagliero E; Copeland PM; Borba CP; Evins AE; Hayden D; Weber MT; Anderson EJ; Allison DB; Daley TB; Schoenfeld D; Goff DC
    Arch Gen Psychiatry; 2005 Jan; 62(1):19-28. PubMed ID: 15630069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.
    Perez-Iglesias R; Crespo-Facorro B; Amado JA; Garcia-Unzueta MT; Ramirez-Bonilla ML; Gonzalez-Blanch C; Martinez-Garcia O; Vazquez-Barquero JL
    J Clin Psychiatry; 2007 Nov; 68(11):1733-40. PubMed ID: 18052567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.